DE60322682D1 - METHOD FOR MONITORING TYPE II COLLAGEN DISSIPATION IN CARTLES - Google Patents

METHOD FOR MONITORING TYPE II COLLAGEN DISSIPATION IN CARTLES

Info

Publication number
DE60322682D1
DE60322682D1 DE60322682T DE60322682T DE60322682D1 DE 60322682 D1 DE60322682 D1 DE 60322682D1 DE 60322682 T DE60322682 T DE 60322682T DE 60322682 T DE60322682 T DE 60322682T DE 60322682 D1 DE60322682 D1 DE 60322682D1
Authority
DE
Germany
Prior art keywords
collagen
cartles
dissipation
collagen type
monitoring type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60322682T
Other languages
German (de)
Inventor
Jean-Yves Reginster
Michelle Deberg
Yves Henrotin
Stephan Christgau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Liege
Original Assignee
Universite de Liege
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Liege filed Critical Universite de Liege
Application granted granted Critical
Publication of DE60322682D1 publication Critical patent/DE60322682D1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/84—Bones; tendons; teeth; cartilage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Tires In General (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)

Abstract

A method for improving the diagnostic assessment of cartilage degenerative processes, and to provide means of monitoring the effects of therapeutical measures taken towards arthritic diseases in most mammals utilizes an immunoassay to detect fragments of collagen type II resulting from collagenase activity comprising an antibody directed against an epitope comprised in the amino acid sequence HRGYPGLDG (SEQ ID NO:1), located in the helical region of collagen type II.
DE60322682T 2002-03-13 2003-03-12 METHOD FOR MONITORING TYPE II COLLAGEN DISSIPATION IN CARTLES Expired - Lifetime DE60322682D1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36392602P 2002-03-13 2002-03-13
DKPA200200380 2002-03-13
PCT/EP2003/002561 WO2003076947A2 (en) 2002-03-13 2003-03-12 Method for monitoring collagen type ii degradation in cartilage

Publications (1)

Publication Number Publication Date
DE60322682D1 true DE60322682D1 (en) 2008-09-18

Family

ID=27806429

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60322682T Expired - Lifetime DE60322682D1 (en) 2002-03-13 2003-03-12 METHOD FOR MONITORING TYPE II COLLAGEN DISSIPATION IN CARTLES

Country Status (7)

Country Link
US (2) US7410770B2 (en)
EP (1) EP1485718B1 (en)
AT (1) ATE403873T1 (en)
AU (1) AU2003222759A1 (en)
DE (1) DE60322682D1 (en)
ES (1) ES2311696T3 (en)
WO (1) WO2003076947A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010003016A2 (en) * 2008-07-04 2010-01-07 Axial Biotech, Inc Genetic markers associated with degenerative disc disease and uses thereof
KR101705353B1 (en) * 2013-10-17 2017-02-13 경북대학교 산학협력단 Reagent for Diagnosis of Osteoarthritis Comprising Peptide Probe of ApoPep-1
JP6649399B2 (en) * 2014-12-19 2020-02-19 ユニベルシテ・ド・リエージュＵｎｉｖｅｒｓｉｔｅ Ｄｅ Ｌｉｅｇｅ Coll2-1 peptide and its nitrated form for treatment of osteoarthritis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973666A (en) 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
US5702909A (en) 1987-11-06 1997-12-30 Washington Research Foundation Methods of detecting collagen type II degradation in vivo
US6132976A (en) * 1992-12-04 2000-10-17 Shriners Hospitals For Children Immunoassays for the measurement of collagen denaturation and cleavage in cartilage
US6110689A (en) 1994-01-21 2000-08-29 Osteometer A/S Method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
GB9928052D0 (en) 1999-11-26 2000-01-26 Osteometer Biotech As Assay of isomerised and/or optically inverted proteins and protein fragments
EP1420806B1 (en) * 2001-07-12 2013-05-01 Rikard Holmdahl Antibody detection method using triple polypeptide complexes derived from collagen ii

Also Published As

Publication number Publication date
WO2003076947A2 (en) 2003-09-18
EP1485718A2 (en) 2004-12-15
AU2003222759A8 (en) 2003-09-22
ATE403873T1 (en) 2008-08-15
US7410770B2 (en) 2008-08-12
US20050170429A1 (en) 2005-08-04
WO2003076947A3 (en) 2004-04-08
EP1485718B1 (en) 2008-08-06
US20090042220A1 (en) 2009-02-12
ES2311696T3 (en) 2009-02-16
AU2003222759A1 (en) 2003-09-22
US7728112B2 (en) 2010-06-01

Similar Documents

Publication Publication Date Title
NO20043419L (en) New cytokine, zcytor17 ligand
PT638172E (en) METHODS AND COMPOSITIONS FOR MONITORING THE CELL PROCESSING OF PREVIOUS BETA-AMYLOID PROTEIN
UA89616C2 (en) Casein hydrolyzate, process for producing the same and use thereof
MXPA05010827A (en) Identifying a midregional proadrenomedullin partial peptide in biological liquids for diagnostic purposes, and immunoassays for conducting an identification of this type.
ATE520981T1 (en) DIAGNOSIS AND MONITORING OF DISEASES
CY1112330T1 (en) CONNECTION PROTEINS GAG
DE50304608D1 (en) SANDWICH IMMUNOASSAY FOR THE DETERMINATION OF PROANP PARTICLEPEPTIDES
WO2003063760A3 (en) Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
ATE292801T1 (en) METHOD FOR SCREENING INHIBITORS OF ASP2
DE69729954D1 (en) Identification procedure for substances that bind to the Pyk2 polypeptide
MX343630B (en) Means and methods for diagnosing and treating multiple sclerosis.
US20110144310A1 (en) Diagnosis of collagen IX destruction
BR0313918A (en) Process for selective biocatalytic synthesis and modification of peptides, mimetic peptides and proteins
DE60322682D1 (en) METHOD FOR MONITORING TYPE II COLLAGEN DISSIPATION IN CARTLES
DE69940927D1 (en) PEPTIDE FRAGMENTS WITH CELL DEATH PREVENTIVE ACTIVITY
BRPI0306644B8 (en) method for producing a modified peptide
ATE517629T1 (en) USE OF A PROTEIN OF THE CRMP FAMILY TO TREAT IMMUNE SYSTEM DISEASES
DK1587839T3 (en) Light-induced immobilization
ATE499614T1 (en) METHOD FOR DETERMINING A TISSUE DEGRADATION PROCESS BY DETECTING COMP-NEOEPITOPES
DK0769025T3 (en) Methods and compositions related to proteoglycan proteins for the diagnosis of cartilage degradation
DE69938827D1 (en) USE OF INHIBITORS OF ASPARAGINYL ENDOPEPTIDASE FROM MAMMALS FOR MODULATING IMMUNE SYSTEMS
EP1467207A4 (en) Screening method
DE60302764D1 (en) TEST ON PHOSPHOAMIDASE
ATE369381T1 (en) NUCLEAR PROTEIN ßSHOCAß - A COMPONENT OF THE WNT SIGNAL TRANSDUCTION PATHWAY
DE50309626D1 (en) METHOD FOR PREDICTING EXPRESSION EFFICIENCY IN CELL-FREE EXPRESSION SYSTEMS

Legal Events

Date Code Title Description
8364 No opposition during term of opposition